Latest Alterity Therapeutics (ASX:ATH) News
Page 1
Page 1 of 4
Healthcare Wrap - Week 44 (26 Oct -> 30 Oct) 2026
31 Oct 2026
Alterity Moves ATH434 Toward Phase 3 With FDA Alignment and A$41.3 Million Cash
30 Oct 2026
Healthcare Wrap - Week 36 (31 Aug -> 4 Sept) 2026
5 Sept 2026
Alterity Therapeutics Secures Up to A$7.96 Million Through Underwritten ATHO Options
31 Aug 2026
Healthcare Wrap - Week 35 (24 Aug -> 28 Aug) 2026
29 Aug 2026
Alterity Therapeutics Reports Larger Losses Amid FDA Phase 3 Trial Clarity for ATH434
28 Aug 2026
Market Wrap - Week 33 (10 Aug -> 14 Aug) 2026
15 Aug 2026
Healthcare Wrap - Week 33 (10 Aug -> 14 Aug) 2026
15 Aug 2026
Alterity Therapeutics Secures US Patent Extending ATH434 Protection to 2045
12 Aug 2026
Healthcare Wrap - Week 31 (27 July -> 31 July) 2026
1 Aug 2026
Alterity Therapeutics Secures FDA Nod for Single Phase 3 Trial in Multiple System Atrophy
30 July 2026
Healthcare Wrap - Week 28 (6 July -> 10 July) 2026
11 July 2026